|By Business Wire||
|April 3, 2014 03:00 AM EDT||
The most progressive minds in Europe’s pharmaceutical research community will convene at the PRO & eCOA Congress, Europe 3-5 June in Barcelona, Spain. Registration is now open for this educational event centered on the science, technologies and regulatory requirements of PROs and eCOAs.
The Congress is hosted by PHT Corporation, the leading provider of technologies used to collect patient-driven eData for clinical research. PHT provides sponsors and CROs the flexibility to deploy clinical outcome assessments on the web, smartphones and tablets including patients’ own devices.
The Congress is attended by pharmaceutical and biotechnology professionals in clinical operations, outsourcing, data management, eClinical technologies, regulatory affairs, and health outcomes as well as PRO and eCOA thought leaders, regulators and sites. Attendees participate in educational sessions and share experiences with peers during networking activities.
Register here: bit.ly/CongressBarcelona
Sheila Rocchio, MBA, PHT Vice President of Marketing and Product Management, said, “The Congress is a world-class event where eClinical visionaries make serious and meaningful advances in adopting eCOA technologies to enable patient-centric clinical research. There is no other meeting in Europe like the eCOA Congress – 94% of last years’ attendees said they would strongly recommend the meeting to a colleague.” Learn more about the PRO & eCOA Congress in one minute: http://bit.ly/1h39AHS
Speakers include representatives from Celgene, Astellas and other leading pharmaceutical companies, research sites and industry organizations as well as PHT executive leadership. Examples of the type of content attendees receive are reflected in these recent publications that resulted from previous Congress sessions:
- Patients Prefer electronic COA (eCOA) Over Paper PRO
- How to Implement an ePRO Strategy: A Best Practices Guide
- Using ePRO for the First Time; Lessons Learned from a Trial Manager’s Perspective
- New FDA Roadmap App developed by PHT to Easily Navigate the FDA Roadmap to Patient-Focused Outcome Measurement in Clinical Trials
The agenda combines presentations, case studies, workshops and roundtable discussions that focus on the latest PRO and eCOA innovations, case studies and best practices. Learn more here: http://bit.ly/CongressBarcelona.
Meet PHT at the Outsourcing in Clinical Trials Europe, 21-22 May to be entered to win one free PRO & eCOA Congress registration and hotel accommodation in Barcelona. PHT invites all Congress alumni to join the exclusive PRO & eCOA Congress LinkedIn Community to exchange information, ideas and experiences throughout the year.
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.